Diagnostic Radiopharmaceuticals and Their Masses
| Diagnostic radiopharmaceutical | Mass* |
| 15O-H2O, 1,110 MBq (30 mCi) | 5.55 pg |
| 18F-NaF, 370 MBq (10 mCi) | 0.24 ng |
| 18F-FDG, 370 MBq (10 mCi) | 1.06 ng |
| 13N-NH3, 370 MBq (10 mCi) | 400–800 ng |
| 18F-florbetapir, 370 MBq (10 mCi) | About 300 ng |
| 99mTc-TcO4, 370 MBq (10 mCi) | 3.56 ng + variable 99Tc-TcO4 |
| 99mTc-MDP, 370–740 MBq (10–20 mCi), assumes 5 doses per kit | 2 mg of medronate disodium |
| 99mTc-MAG3, 185–370 MBq (5–10 mCi), assumes 5 doses per kit | 0.2 mg of betiatide |
| 99mTc-sestamibi, 740 MBq (20 mCi), assumes 5 doses per kit | 0.2 mg of 2-methoxy isobutyl isonitrile |
| 99mTc-MAA, 148 MBq (4 mCi), assumes 10 doses per kit | ∼0.1 mg of aggregated albumin |
| 99mTc-exametazime, 740 MBq (20 mCi), assumes 1 dose per kit | 0.5 mg of exametazine |
| 99mTc-sulfur colloid, 185 MBq (5 mCi), assumes 10 doses per kit | 0.19 mg of sodium thiosulfate and 0.53 mg of gelatin |
| 99mTc-DTPA, 370 MBq (10 mCi), assumes 10 doses per kit | 0.5 mg of pentasodium pentetate |
| 99mTc-disofenin, 185 MBq (5 mCi), assumes 10 doses per kit | 2.0 mg of disofenin |
| 99mTc-DMSA, 185 MBq (5 mCi), assumes 5 doses per kit | 0.24 mg of succimer |
| 111In-DTPA, 18.5 MBq (500 μCi) | 10–25 μg of pentetic acid |
| 201Tl-chloride, 111 MBq (3 mCi) | 16.6 ng of 201Tl |
| 123I-NaI, 14.8 MBq (400 μCi) | 0.246 ng |
| 123I-hippuran, 37 MBq (1 mCi) | 2 mg of iodohippurate sodium |
↵* Compounds added for isotonicity, pH adjustment, stabilization, reduction, and preservation are not included because they are already judged safe.
Variations are due to variable carrier concentrations, frequency of generator milking, time elapsed since radiopharmaceutical preparation, and number of doses prepared per kit.